Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

57 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Association between combination antibiotic therapy as opposed as monotherapy and outcomes of ICU patients with Pseudomonas aeruginosa ventilator-associated pneumonia: an ancillary study of the iDIAPASON trial.
Foucrier A, Dessalle T, Tuffet S, Federici L, Dahyot-Fizelier C, Barbier F, Pottecher J, Monsel A, Hissem T, Lefrant JY, Demoule A, Constantin JM, Rousseau A, Simon T, Leone M, Bouglé A; iDIAPASON Trial Investigators. Foucrier A, et al. Among authors: tuffet s. Crit Care. 2023 May 30;27(1):211. doi: 10.1186/s13054-023-04457-y. Crit Care. 2023. PMID: 37254209 Free PMC article. Clinical Trial.
Randomised trial of first-line bronchial artery embolisation for non-severe haemoptysis of mild abundance.
Fartoukh M, Demoule A, Sanchez O, Tuffet S, Bergot E, Godet C, Andrejak C, Pontier-Marchandise S, Parrot A, Mayaux J, Meyer G, Cluzel P, Sapoval M, Le Pennec V, Carette MF, Cadranel J, Rousseau A, Khalil A, Simon T; ARTEMHYS trial group. Fartoukh M, et al. Among authors: tuffet s. BMJ Open Respir Res. 2021 Jun;8(1):e000949. doi: 10.1136/bmjresp-2021-000949. BMJ Open Respir Res. 2021. PMID: 34088727 Free PMC article. Clinical Trial.
Comparison of 8 versus 15 days of antibiotic therapy for Pseudomonas aeruginosa ventilator-associated pneumonia in adults: a randomized, controlled, open-label trial.
Bouglé A, Tuffet S, Federici L, Leone M, Monsel A, Dessalle T, Amour J, Dahyot-Fizelier C, Barbier F, Luyt CE, Langeron O, Cholley B, Pottecher J, Hissem T, Lefrant JY, Veber B, Legrand M, Demoule A, Kalfon P, Constantin JM, Rousseau A, Simon T, Foucrier A; iDIAPASON Trial Investigators. Bouglé A, et al. Among authors: tuffet s. Intensive Care Med. 2022 Jul;48(7):841-849. doi: 10.1007/s00134-022-06690-5. Epub 2022 May 13. Intensive Care Med. 2022. PMID: 35552788 Clinical Trial.
Correction to: Comparison of 8 versus 15 days of antibiotic therapy for Pseudomonas aeruginosa ventilator-associated pneumonia in adults: a randomized, controlled, open-label trial.
Bouglé A, Tuffet S, Federici L, Leone M, Monsel A, Dessalle T, Amour J, Dahyot-Fizelier C, Barbier F, Luyt CE, Langeron O, Cholley B, Pottecher J, Hissem T, Lefrant JY, Veber B, Legrand M, Demoule A, Kalfon P, Constantin JM, Rousseau A, Simon T, Foucrier A; iDIAPASON Trial Investigators. Bouglé A, et al. Among authors: tuffet s. Intensive Care Med. 2022 Jul;48(7):992-994. doi: 10.1007/s00134-022-06776-0. Intensive Care Med. 2022. PMID: 35727349 No abstract available.
Respiratory multiplex PCR and procalcitonin to reduce antibiotic exposure in severe SARS-CoV-2 pneumonia: a multicentre randomized controlled trial.
Fartoukh M, Nseir S, Mégarbane B, Cohen Y, Lafarge A, Contou D, Thille AW, Galerneau LM, Reizine F, Cour M, Klouche K, Navellou JC, Bitker L, Rousseau A, Tuffet S, Simon T, Voiriot G; MultiCoV collaborative trial group. Fartoukh M, et al. Among authors: tuffet s. Clin Microbiol Infect. 2023 Jun;29(6):734-743. doi: 10.1016/j.cmi.2023.01.009. Epub 2023 Jan 18. Clin Microbiol Infect. 2023. PMID: 36681325 Free PMC article. Clinical Trial.
57 results